Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
4057 | 1781 | 49.1 | 91% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ERYTHROPOIETIN | Author keyword | 160 | 17% | 49% | 879 |
2 | CELLULAR MOL CEREBRAL I EMIA | Address | 134 | 89% | 3% | 62 |
3 | CARBAMYLATED ERYTHROPOIETIN | Author keyword | 33 | 77% | 1% | 23 |
4 | ASIALOERYTHROPOIETIN | Author keyword | 21 | 90% | 1% | 9 |
5 | ERYTHROPOIETIN RECEPTOR | Author keyword | 20 | 24% | 4% | 71 |
6 | EPO | Author keyword | 11 | 17% | 3% | 60 |
7 | CEPO | Author keyword | 9 | 83% | 0% | 5 |
8 | EPO RECEPTOR | Author keyword | 9 | 47% | 1% | 14 |
9 | MOL MED GENET ENVIRONM HLTH SCI | Address | 6 | 71% | 0% | 5 |
10 | ARA290 | Author keyword | 6 | 100% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ERYTHROPOIETIN | 160 | 17% | 49% | 879 | Search ERYTHROPOIETIN | Search ERYTHROPOIETIN |
2 | CARBAMYLATED ERYTHROPOIETIN | 33 | 77% | 1% | 23 | Search CARBAMYLATED+ERYTHROPOIETIN | Search CARBAMYLATED+ERYTHROPOIETIN |
3 | ASIALOERYTHROPOIETIN | 21 | 90% | 1% | 9 | Search ASIALOERYTHROPOIETIN | Search ASIALOERYTHROPOIETIN |
4 | ERYTHROPOIETIN RECEPTOR | 20 | 24% | 4% | 71 | Search ERYTHROPOIETIN+RECEPTOR | Search ERYTHROPOIETIN+RECEPTOR |
5 | EPO | 11 | 17% | 3% | 60 | Search EPO | Search EPO |
6 | CEPO | 9 | 83% | 0% | 5 | Search CEPO | Search CEPO |
7 | EPO RECEPTOR | 9 | 47% | 1% | 14 | Search EPO+RECEPTOR | Search EPO+RECEPTOR |
8 | ARA290 | 6 | 100% | 0% | 4 | Search ARA290 | Search ARA290 |
9 | RHEPO | 4 | 23% | 1% | 14 | Search RHEPO | Search RHEPO |
10 | SOLUBLE ERYTHROPOIETIN RECEPTOR | 3 | 57% | 0% | 4 | Search SOLUBLE+ERYTHROPOIETIN+RECEPTOR | Search SOLUBLE+ERYTHROPOIETIN+RECEPTOR |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CARBAMYLATED ERYTHROPOIETIN | 40 | 76% | 2% | 28 |
2 | TISSUE PROTECTION | 29 | 52% | 2% | 40 |
3 | MICE OVEREXPRESSING ERYTHROPOIETIN | 28 | 62% | 2% | 29 |
4 | PERMANENT CEREBRAL ISCHEMIA | 27 | 76% | 1% | 19 |
5 | NEURONAL ENDONUCLEASE ACTIVITY | 25 | 77% | 1% | 17 |
6 | DOSE RECOMBINANT ERYTHROPOIETIN | 25 | 71% | 1% | 20 |
7 | INFLAMMATORY MICROGLIAL ACTIVATION | 23 | 72% | 1% | 18 |
8 | ANALOG DARBEPOETIN ALPHA | 18 | 83% | 1% | 10 |
9 | ENDOTHELIAL PROGENITOR CELL | 14 | 57% | 1% | 17 |
10 | NAD PRECURSOR NICOTINAMIDE | 13 | 61% | 1% | 14 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The non-haematopoietic biological effects of erythropoietin | 2008 | 185 | 188 | 70% |
Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response | 2008 | 152 | 189 | 72% |
Therapeutic Potential of Erythropoietin and its Structural or Functional Variants in the Nervous System | 2009 | 89 | 130 | 76% |
Discovering erythropoietin's extra-hematopoietic functions: Biology and clinical promise | 2006 | 160 | 25 | 80% |
Erythropoietin: multiple targets, actions, and modifying influences for biological and clinical consideration | 2013 | 26 | 23 | 39% |
Erythropoietin 2nd cerebral protection after acute injuries: A double-edged sword? | 2010 | 37 | 216 | 78% |
Emerging biological roles for erythropoietin in the nervous system | 2005 | 265 | 99 | 67% |
Erythropoietin and the heart: Physiological effects and the therapeutic perspective | 2014 | 7 | 146 | 51% |
The Receptor That Tames the Innate Immune Response | 2012 | 20 | 83 | 61% |
Erythropoietin Action in Stress Response, Tissue Maintenance and Metabolism | 2014 | 7 | 216 | 50% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CELLULAR MOL CEREBRAL I EMIA | 134 | 89% | 3.5% | 62 |
2 | MOL MED GENET ENVIRONM HLTH SCI | 6 | 71% | 0.3% | 5 |
3 | CELLULAR MOL SIGNALING | 5 | 43% | 0.5% | 9 |
4 | SECT EXPT NEUROSURG | 4 | 67% | 0.2% | 4 |
5 | ENVIRONM HLTH SCI MOL MED GENET | 4 | 75% | 0.2% | 3 |
6 | MOL MED BRANCH | 4 | 18% | 1.0% | 18 |
7 | MOL MED GENET ANAT CELL BIOL | 3 | 100% | 0.2% | 3 |
8 | MOL MED GENET MOL CELLULAR TOXICOL | 3 | 100% | 0.2% | 3 |
9 | NEUROL CELLULAR MOL CEREBRAL I EMIA | 2 | 67% | 0.1% | 2 |
10 | NBG THG | 2 | 50% | 0.2% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000127222 | ERYTHROPOIETIN RECEPTOR//STEM PROGENITOR CELL BIOL PROGRAM//ERYTHROBLAST MACROPHAGE PROTEIN |
2 | 0.0000117921 | CHEMOTHERAPY INDUCED ANEMIA//EPOETIN ALFA//CHEMOTHERAPY INDUCED ANAEMIA |
3 | 0.0000110512 | ANTIANEMIC AGENTS//CAS 11096 26 7//RECOMBINANT HUMAN ERYTHROPOIETIN RHEPO |
4 | 0.0000096073 | HYPOXIA ISCHEMIA HI//NEUROPROTECTIVE THERAPY//INHA NEURAL REPAIR |
5 | 0.0000083267 | ERYTHROPOIETIN//DARBEPOETIN ALFA//RENAL ANEMIA |
6 | 0.0000081045 | CARDIORENAL ANEMIA SYNDROME//CONGEST HEART FAILURE UNIT//PL CARDIOVASC SYST |
7 | 0.0000060280 | 1 METHYLNICOTINAMIDE//NICOTINAMIDE N METHYLTRANSFERASE//NNMT |
8 | 0.0000058203 | ANEMIA OF PREMATURITY//PLACENTAL TRANSFUSION//ANAEMIA OF PREMATURITY |
9 | 0.0000047313 | NUCLEATED RED BLOOD CELLS//NUCLEATED RED BLOOD CELL//NUCLEATED RED BLOOD CELL COUNT |
10 | 0.0000038482 | BRAIN VASCULARITY//NEUROVASCULAR NICHE//BRAIN CAPILLARY DENSITY |